Assessment of the Impact of the Return Home of Premature Newborns With Intrauterine Growth Retardation Weighing Less Than 2 Kilos on Short- and Long-term Morbidity/Mortality

What this Trial Is About

This research aims to evaluate the effects of discharging premature newborns weighing less than 2 kilograms from the hospital. The study focuses on both short-term and long-term outcomes for these infants who were treated at the NOVO hospital's neonatology department between 2012 and 2024. Prematurity and low birth weight are significant public health concerns, and advances in neonatal care along with parental involvement have reduced mortality rates among these vulnerable babies. Participants include premature newborns with intrauterine growth retardation discharged home weighing under 2 kilos. Data is collected through questionnaires completed by mothers and fathers, either on paper or by phone, covering the period from discharge until the baby reaches up to 11 months of age. The study also considers parental support and medical opinions regarding discharge weight criteria. During the study, researchers observe various health indicators including growth in weight, height, and head circumference, as well as morbidity and incidence of Sudden Unexplained Infant Death Syndrome (SUIDS). Parents' experiences and the support they receive are also assessed remotely. The main outcome is the short-term health status of these newborns at an average of 11 months post-discharge, with additional evaluations at around 6 months. Participation involves completing questionnaires and data collection related to the infant's health and development.

Assessment of the Impact of the Return Home of Premature Newborns Less Than 2 Kilos Morbidity/Mortality